Screening a Targeted Panel of Genes by Next-Generation Sequencing Improves Risk Stratification in Real World Patients with Acute Myeloid Leukemia

Screening a Targeted Panel of Genes by Next-Generation Sequencing Improves Risk Stratification in Real World Patients with Acute Myeloid Leukemia

Although mutation profiling of defined genes is recommended for classification of acute myeloid leukemia (AML) patients, screening of targeted gene panels using next-generation sequencing (NGS) is not always routinely used as standard of care. The objective of this study was to prospectively assess...

Full description

Bibliographic Details
Main Authors: Sónia Matos, Paulo Bernardo, Susana Esteves, Aida Botelho de Sousa, Marcos Lemos, Patrícia Ribeiro, Madalena Silva, Albertina Nunes, Joana Lobato, Maria de Jesus Frade, Maria Gomes da Silva, Sérgio Chacim, José Mariz, Graça Esteves, João Raposo, Ana Espadana, José Carda, Pedro Barbosa, Vânia Martins, Maria Carmo-Fonseca, Joana Desterro
Format: Article
Language:English
Published: MDPI AG 2022-06-01
Series:Cancers
Subjects:
AML
high-throughput sequencing
risk stratification
Online Access:https://www.mdpi.com/2072-6694/14/13/3236

Internet

https://www.mdpi.com/2072-6694/14/13/3236

Similar Items